Effect of (1)H‐NMR serum lipoproteins on immunotherapy response in advanced triple‐negative breast cancer patients

We previously reported the results of a phase II trial of anti‐PD‐1 antibody plus anti‐vascular endothelial growth factor receptor 2 inhibitors and eribulin in heavily pretreated advanced triple‐negative breast cancer with a favorable objective response rate (ORR) of 37.0% (NCT04303741). Here we rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Zhenluan, Rao, Qunxian, He, Zhanghai, Zhao, Wei, Chen, Liangyu, Liu, Jieqiong, Wang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551590/
https://www.ncbi.nlm.nih.gov/pubmed/37640025
http://dx.doi.org/10.1111/cas.15937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551590/
https://www.ncbi.nlm.nih.gov/pubmed/37640025
http://dx.doi.org/10.1111/cas.15937

Ejemplares similares